Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06725108 · ClinicalTrials.gov registry record

Hemodynamic ABI Monitor

A clinical trial of Intracerebral Hemorrhage and Traumatic Brain Injury (TBI), sponsored by University of Chicago.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT06725108 is a study of Intracerebral Hemorrhage and Traumatic Brain Injury (TBI) that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 50 participants, below the 1,174-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06725108, a study of Intracerebral Hemorrhage and Traumatic Brain Injury (TBI), is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to explore the relationship of heart function with the course and outcomes after traumatic brain injuries and nontraumatic intracerebral hemorrhage. The goal is to explore association between routinely collected hemodynamic and brain monitoring data. Participants already taking intervention A as part of their regular medical care and the investigators will follow up with participants 6 months after discharging the hospital.

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-12-06
Est. Completion 2026-12-06

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT06725108

The ClinicalTrials.gov registry entry for NCT06725108 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,174-participant average among 29 other Intracerebral Hemorrhage trials with a reported enrollment target (96% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Intracerebral Hemorrhage appearing as the primary indexed condition, and to 0 interventions.

NCT06725108 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06725108 about?

NCT06725108 is a clinical study titled "Hemodynamic ABI Monitor". The goal of this observational study is to explore the relationship of heart function with the course and outcomes after traumatic brain injuries and nontraumatic intracerebral hemorrhage. The goal is to explore association between routinely collected hemodynamic and brain monitoring data. Particip...

What is the current status of trial NCT06725108?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-12-06. Estimated completion is 2026-12-06.

What conditions does trial NCT06725108 study?

This clinical trial studies the following conditions: Intracerebral Hemorrhage, Traumatic Brain Injury (TBI).

Who is sponsoring clinical trial NCT06725108?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06725108 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intracerebral Hemorrhage

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.